The effect of transurethral resection of the prostate on lymphocyte response in patients with prostatic cancer.
The following study indicates that transurethral resection may affect the in vivo cellular aspects of the immune response in patients with prostatic cancer. This in vivo result seems to be supported by the fact that patients dying of carcinoma of the prostate at our institution usually had had an antecedent transurethral resection. Therefore, we emphasize that transurethral resection in patients with prostate cancer should be undertaken with clear-cut indications and with the knowledge that it may be an insult to the patient's immune system.
D000368:Aged; D000917:Antibody Formation; D006801:Humans; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000601:surgery*; D011471:Prostatic Neoplasms / Q000276:immunology* / Q000601:surgery
D037102:Lectins